NeuroSky
PrivateLast Round
Series D
Nov 7, 2013
Total Funding Raised
$18.97M
Company Overview
NeuroSky operates in Healthcare & Life Sciences and is based in San Jose, California. Its latest recorded funding round was a Series D round in November 2013.
NeuroSky is a biosensor technology company that develops and manufactures brain-computer interface (BCI), EEG, and ECG technologies for consumer and commercial applications.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Sensors, Consumer Electronics, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroSky Comparables
Compare NeuroSky with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Emotiv | 82% | |
| BrainBit | 82% | |
| Neurable | 80% |
For institutional investors. Book with your work email.
NeuroSky Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Nov 7, 2013 | ||||
| Series C | Jun 22, 2010 |
For institutional investors. Book with your work email.
NeuroSky Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Taiwan United Venture Capital Corporation | Series A |
| SoftBank Group | Series D |
| WR Hambrecht + Co | Series A, Series C |
| YFY Biotech Management Company | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 17, 2025
Partnered with ZKTeco to advance emotion-aware BCI technologies.
- Mar 1, 2025
Monthly visitors increased 4690% MoM, reaching 47.9K.
For institutional investors. Book with your work email.
NeuroSky Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NeuroSky's valuation, stock price, and market status.
Is NeuroSky a public or private company?
NeuroSky is a private company.
What is the current stock price of NeuroSky?
NeuroSky is a private company, so its shares have no public market price. Caplight tracks NeuroSky's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NeuroSky worth (valuation)?
Valuation information for NeuroSky is not publicly available.
Can I buy NeuroSky stock?
NeuroSky shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NeuroSky's last funding round?
NeuroSky's most recent funding round was Series D on November 7, 2013.
Who are the main investors in NeuroSky?
Key investors in NeuroSky include SoftBank Group, WR Hambrecht + Co.
Will NeuroSky IPO soon?
No public IPO plans have been announced for NeuroSky.
How can I track NeuroSky secondary market activity?
Caplight tracks bids, offers, and trades in NeuroSky's shares on secondary markets.